Inhibition of vascular endothelial growth factor‐A downregulates angiogenesis in psoriasis: A pilot study
Abstract Background Vascular Endothelial Growth Factor (VEGF)‐A‐mediated angiogenesis participates in the pathogenesis of psoriasis, thus inviting the hypothesis that anti‐VEGF‐A therapy could be beneficial in psoriasis. While anti‐angiogenic agents are used in oncology and ophthalmology, these ther...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Skin Health and Disease |
Online Access: | https://doi.org/10.1002/ski2.245 |